Literature DB >> 10501714

Drug abuse-related mortality: a study of teenage addicts over a 20-year period.

A Oyefeso1, H Ghodse, C Clancy, J Corkery, R Goldfinch.   

Abstract

BACKGROUND: There is growing concern about increase in illicit drug use and associated fatalities in young people.
METHOD: This longitudinal analysis of successive cohorts of addicts in England and Wales aged 15-19 years followed up over a 20-year period covering 1974 to 1993 (1) investigated trends in all-causes mortality; (2) examined teenage-specific mortality, i.e. deaths during ages 15-19 years; (3) determined excess teenage-specific mortality; and (4) identified the main underlying causes of teenage-specific death in this population. The main outcome measures were overall mortality rates, teenage-specific mortality and standardised mortality ratios calculated for four 5-year (period) successive cohorts.
RESULTS: Overall mortality rate in the study population (N = 9491) was 4.7/1000 person-years. The median age at death was 23 years (semi interquartile range = 3), with the majority (91.3%) of deaths occurring between ages 15 and 29 years. Excess teenage-specific mortality in the population was 10.7 in males and 21.2 in females (general population = 1), and increase in excess mortality in both sexes was evident in the last 5-year period of study. The majority of deaths (64.3%) resulted from accidental poisoning. Methadone and heroine/morphine accounted for about two-thirds of accidental poisoning deaths, while suicide accounted for 11.4% of teenage-specific deaths.
CONCLUSIONS: It is strongly recommended that treatment services should be more responsive to the need for careful prescribing, dispensing and administration of substitute medication to teenage addicts in their care. The development of needs-led, case-sensitive treatment services for young addicts is indicated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10501714     DOI: 10.1007/s001270050166

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  9 in total

1.  Cardiovascular complications of recreational drugs.

Authors:  A Ghuran; L R van Der Wieken; J Nolan
Journal:  BMJ       Date:  2001-09-01

2.  The epidemiology of self-poisoning in the UK.

Authors:  D R Camidge; R J Wood; D N Bateman
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

3.  Risk of mortality during four years after substance detoxification in urban adults.

Authors:  Richard Saitz; Jessie Gaeta; Debbie M Cheng; Jessica M Richardson; Mary Jo Larson; Jeffrey H Samet
Journal:  J Urban Health       Date:  2007-03       Impact factor: 3.671

Review 4.  Misuse of and dependence on opioids: study of chronic pain patients.

Authors:  Meldon Kahan; Anita Srivastava; Lynn Wilson; Douglas Gourlay; Deana Midmer
Journal:  Can Fam Physician       Date:  2006-09       Impact factor: 3.275

Review 5.  Use and misuse of drugs and alcohol in adolescence.

Authors:  Paul McArdle
Journal:  BMJ       Date:  2008-06-30

6.  Drug abuse-associated mortality across the lifespan: a population-based longitudinal cohort and co-relative analysis.

Authors:  Kenneth S Kendler; Henrik Ohlsson; Kristina Sundquist; Jan Sundquist
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-05-26       Impact factor: 4.328

7.  Mortality in young offenders: retrospective cohort study.

Authors:  Carolyn Coffey; Friederike Veit; Rory Wolfe; Eileen Cini; George C Patton
Journal:  BMJ       Date:  2003-05-17

8.  [Current consumer conditions among opioid addicts--implications for maintenance-treatment programmes provided by ambulatory drug treatment centers and physicians].

Authors:  Salvatore M Giacomuzzi; Markus Ertl; Yvonne Riemer; Haimo Rössler; Alexander Vigl; Hartmann Hinterhuber; Markus Kurz
Journal:  Wien Klin Wochenschr       Date:  2004-02-28       Impact factor: 1.704

9.  A 20-year prospective study of mortality and causes of death among hospitalized opioid addicts in Oslo.

Authors:  Mari A Bjornaas; Anette S Bekken; Aasa Ojlert; Tor Haldorsen; Dag Jacobsen; Morten Rostrup; Oivind Ekeberg
Journal:  BMC Psychiatry       Date:  2008-02-13       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.